Related Experiment Video
Updated: Feb 23, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Core-shell hybrid nanostructured delivery platforms for advanced RNAi therapeutics
S Sajeesh1, Jeong Yong Choe1, Dong Ki Lee1
1Global Research Laboratory for RNAi Medicine, Department of Chemistry, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
This study developed an advanced nanoparticle platform for delivering nonclassical RNA interference (RNAi) triggers. This novel combination enhances RNAi-based therapeutic development for improved treatment strategies.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- RNA interference (RNAi) offers therapeutic potential but requires effective delivery systems.
- Nonclassical RNAi triggers present unique structural and delivery challenges.
- Nanoparticle platforms can enhance oligonucleotide delivery and stability.
Purpose of the Study:
- To combine nonclassical RNAi triggers with advanced nanoparticle delivery systems.
- To develop efficient therapeutic systems for RNAi-based treatments.
- To evaluate the efficacy of a novel core-shell hybrid nanostructured platform.
Main Methods:
- A core-shell hybrid nanostructured platform was synthesized using gold nanoparticles.
- Thiol-modified cationic polymers were anchored to the gold nanoparticle surface.
- Nonclassical RNAi triggers, including long double-stranded interfering RNA and tripodal interfering RNA, were complexed via electrostatic interactions.
Main Results:
- The core-shell nanostructured platform effectively delivered nonclassical RNAi triggers.
- Successful complexation of RNAi candidates with the nanoparticle platform was achieved.
- The combined system demonstrated potential for advanced RNAi-based therapeutics.
Conclusions:
- The integration of nonclassical RNAi structures with the core-shell nanostructured platform is a promising strategy.
- This approach represents an effective module for developing advanced RNAi-based therapeutics.
- Further research into this platform could lead to novel therapeutic interventions.
More Related Videos
08:53Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
09:23Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"
Published on: March 31, 2021
Related Concept Videos
Experimental RNAi
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Drug Delivery Systems: Different Types
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...